[The pathophysiology of irritable bowel syndrome].
The irritable bowel syndrome (IBS) is a frequent gastrointestinal disorder (10 -15% of the population). It is characterized by chronic abdominal pain with modification in the bowel habits. The diagnosis is based of ROME II criteria. The pathophysiology of the SII remains unknown . It result from visceral hypersensitivity with anomalies of the digestive motility. These anomalies are secondary of dysfunction of the brain - gut axis modulated by environmental and the psychosocial factors. The understanding of the pathophysiological mechanisms of the SII and in particular the function of the brain-gut axis will permit a better handling of the patients. Indeed, the present knowledge of the neurotransmitter implied in the communication between the central nervous system and the digestive tract are currently the basis of the new therapies aimed to modulate the mechanisms implicated in the causation of the several symptoms of IBS. These novel pharmacotherapy should reduce the indirect societal and costs of IBS.
Zouiten
Mekki Lilia
ML
Laboratoire de PInsiologie, Faculté de Médecine de Tunis, Tunisie.
Karoui
Sami
S
Boubaker
Jalel
J
Fekih
Monia
M
Mechmeche
Rachid
R
Filali
Azza
A
D001921:Brain / Q000503:physiopathology; D005769:Gastrointestinal Motility / Q000502:physiology; D041981:Gastrointestinal Tract / Q000294:innervation / Q000503:physiopathology; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000503:physiopathology*; D009434:Neural Pathways / Q000503:physiopathology; D018377:Neurotransmitter Agents / Q000502:physiology
D018377:Neurotransmitter Agents